Latest Distributions News

Elanor Commercial Property Fund’s Independent Board Committee has unanimously recommended rejecting Lederer Group’s unsolicited $0.70 per security takeover offer, citing significant undervaluation and strategic risks. The committee advises securityholders to take no action until a detailed target’s statement is released.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

Ausbil Investment Management has launched the Ausbil Active Dividend Income Fund – Active ETF, targeting tax effective income and potential capital growth through an actively managed Australian equities portfolio. The Fund will trade on the ASX AQUA market under ticker DIVI, featuring a 0.85% management fee and monthly distributions.

Telstra Group Limited has confirmed a fully franked ordinary dividend of 9.5 cents per share for the first half of FY25, alongside an updated Dividend Reinvestment Plan price reflecting recent trading activity.

Samuel Terry Asset Management has launched an off-market takeover offer for all Eildon Capital Group stapled securities at A$0.80 per security, representing a notable premium over recent trading prices. The move aims to consolidate ownership and potentially delist Eildon Capital from the ASX.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Heartland Group Holdings updates its dividend distribution details for the first half of 2025, confirming an unfranked ordinary dividend and a supplementary dividend with a revised DRP strike price.

Deterra Royalties Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.13 per share for the half-year ending June 2025, alongside a recalculated Dividend Reinvestment Plan price.

Lode Resources has agreed to sell its Webbs Consol Silver Project to Rapid Critical Metals for A$3.75 million cash, 115 million shares, and a 2% royalty, consolidating high-grade silver assets in New South Wales.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Lake Resources N.L. has launched a prospectus offering up to 271.7 million new options linked to a recent A$12 million placement, aiming to advance its flagship Kachi lithium project. The options, exercisable at A$0.05 and expiring in three years, await shareholder approval and align management with investors.

Marquee Resources has confirmed consistently high-grade antimony mineralisation at its Mt Clement (Eastern Hills) Project, setting the stage for a maiden JORC resource estimate expected within two weeks.